Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital
- 26 July 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 152 (1-2), 9-17
- https://doi.org/10.1016/0014-2999(88)90830-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A simple intravenous Infusion Technique for Mice. Method and some Applications.Acta Pharmacologica et Toxicologica, 2009
- MK-801, NMDA receptors and ischaemia-induced neurodegenerationTrends in Pharmacological Sciences, 1987
- Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonistEuropean Journal of Pharmacology, 1987
- Excitatory amino acid synaptic mechanisms and neurological functionTrends in Pharmacological Sciences, 1986
- CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]d-AP5 binding sites on brain membranes and anticonvulsant activityBrain Research, 1986
- Muscle relaxant action of phenobarbitone in genetically spastic rats: an electromyographic studyEuropean Journal of Pharmacology, 1986
- Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agentsEuropean Journal of Pharmacology, 1985
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Antiepileptic Drug Development: II. Anticonvulsant Drug ScreeningEpilepsia, 1978
- Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminéePharmacology, 1960